TABLE 6.
Impacts of the interventions at the clinical, economic, and organizational levels in the study participants at HGH (n = 183).
| Score | Impact | Frequency (%) |
|---|---|---|
| Clinical impact | ||
| -1C | Negative | 7 (4.9) |
| 0C | Null | 5 (3.5) |
| 1C | Minor | 52 (36.3) |
| 2C | Moderate | 30 (21.0) |
| 3C | Major | 12 (8.4) |
| 4C | Avoid fatality | 2 (1.4) |
| UND | Undetermined | 35 (24.5) |
| Economic impact | ||
| -1C | Increased cost | 34 (23.8) |
| 0C | No change | 14 (9.8) |
| 1C | Decreased cost | 69 (48.2) |
| UND | Undetermined | 26 (18.2) |
| Organizational impact | ||
| -1O | Negative | 20 (14.0) |
| 0O | Null | 45 (31.4) |
| 1O | Positive | 41 (28.7) |
| UND | Undetermined | 37 (25.9) |